Analysis from the Randomized Phase 3 Aspire Trial - Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide & Dexamethasone

Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses the analysis from the randomized phase 3 Aspire trial and Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide &... Author: ASHReport Added: 01/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts